BioMarin Pharmaceutical (BMRN) Quick Ratio: History & Chart

BioMarin Pharmaceutical Inc.(BMRN)

Biotechnology · San Rafael, CA

$56.22-1.32 (-2.29%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage disorder, and Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for individuals with MPS VI. Another notable offering is Kuvan, a unique synthetic oral version of 6R-BH4, prescribed for phenylketonuria (PKU), an inherited metabolic condition. Further expanding its product portfolio, BioMarin provides Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme administered via subcutaneous injection to lower blood Phe levels. Also available are Brineura, a recombinant human tripeptidyl peptidase 1 used in treating ceroid lipofuscinosis type 2, a variant of Batten disease; Voxzogo, a daily injectable c-type natriuretic peptide analog for achondroplasia; and Aldurazyme, a refined protein mirroring the naturally occurring human enzyme alpha-L-iduronidase. Beyond its established products, BioMarin has a robust development pipeline. This includes valoctocogene roxaparvovec, an adeno-associated virus vector undergoing Phase III clinical trials for severe hemophilia A. Additionally, BMN 307, an AAV5-mediated gene therapy, is in Phase 1/2 trials, aiming to normalize blood phenylalanine levels in PKU patients, while BMN 255 is also in Phase 1/2 trials for primary hyperoxaluria. Its clientele spans specialty pharmacies, hospitals, international government health bodies, and a network of distributors and pharmaceutical wholesalers. These services reach patients and healthcare providers across the United States, Europe, Latin America, and other global markets. BioMarin maintains strategic licensing and collaborative alliances with partners such as Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. Established in 1996, the company's corporate headquarters are located in San Rafael, California.

San Rafael, CA

3,221 employees

www.biomarin.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Alexander Hardy

View full financials

BMRN Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.32

QUICK RATIO (ACID-TEST) AVG TTM

3.14

QUICK RATIO (ACID-TEST) AVG 3Y

2.71

QUICK RATIO (ACID-TEST) AVG 5Y

2.94

QUICK RATIO (ACID-TEST) AVG 10Y

2.78

QUICK RATIO (ACID-TEST) AVG 15Y

3.09

QUICK RATIO (ACID-TEST) AVG 20Y

3.75

CURRENT VS TTM AVG

-58.14%

CURRENT VS 3Y AVG

-51.54%

CURRENT VS 5Y AVG

-55.19%

CURRENT VS 10Y AVG

-52.62%

CURRENT VS 15Y AVG

-57.37%

CURRENT VS 20Y AVG

-64.92%

SECTOR MEDIAN · HEALTHCARE

3.35

median of 871 covered companies

CURRENT VS SECTOR MEDIAN

-60.73%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
BioMarin Pharmaceutical Inc. (BMRN)	$10.87B	1.32	3.14	2.71	2.94
The Cooper Companies, Inc. (COO)vs ›	$11.01B	0.73	1.13	0.99	0.98
Universal Health Services, Inc. (UHS)vs ›	$10.72B	1.04	1.07	1.16	1.16
Twist Bioscience Corporation (TWST)vs ›	$10.40B	2.38	3.94	4.84	6.08
Bio-Techne Corporation (TECH)vs ›	$11.34B	3.35	2.87	2.99	2.87
Globus Medical, Inc. (GMED)vs ›	$10.31B	2.93	2.25	2.88	3.49
Madrigal Pharmaceuticals, Inc. (MDGL)vs ›	$11.47B	2.94	4.83	4.54	4.64
10x Genomics, Inc. (TXG)vs ›	$10.24B	5.25	4.17	4.17	4.87
Molina Healthcare, Inc. (MOH)vs ›	$10.19B	1.68	1.66	1.58	1.56
DaVita Inc. (DVA)vs ›	$11.58B	1.41	1.23	1.19	1.21

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

BioMarin Pharmaceutical Inc. (BMRN)

$10.87B

1.32

3.14

2.71

2.94

The Cooper Companies, Inc. (COO)vs ›

$11.01B

0.73

1.13

0.99

0.98

Universal Health Services, Inc. (UHS)vs ›

$10.72B

1.04

1.07

1.16

Twist Bioscience Corporation (TWST)vs ›

$10.40B

2.38

3.94

4.84

6.08

Bio-Techne Corporation (TECH)vs ›

$11.34B

3.35

2.87

2.99

2.87

Globus Medical, Inc. (GMED)vs ›

$10.31B

2.93

2.25

2.88

3.49

Madrigal Pharmaceuticals, Inc. (MDGL)vs ›

$11.47B

2.94

4.83

4.54

4.64

10x Genomics, Inc. (TXG)vs ›

$10.24B

5.25

4.17

4.87

Molina Healthcare, Inc. (MOH)vs ›

$10.19B

1.68

1.66

1.58

1.56

DaVita Inc. (DVA)vs ›

$11.58B

1.41

1.23

1.19

1.21

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for BioMarin Pharmaceutical Inc. (BMRN)?

The quick ratio (acid-test) for BMRN stock is 1.32.

Is BioMarin Pharmaceutical Inc.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 1.32 is 55% below its 5-year average of 2.94, near the low end of its 5-year range (1.32–4.20).

What is the TTM average quick ratio (acid-test) for BioMarin Pharmaceutical Inc. (BMRN)?

The TTM average quick ratio (acid-test) for BMRN stock is 3.14.

What is the 3Y average quick ratio (acid-test) for BioMarin Pharmaceutical Inc. (BMRN)?

The 3Y average quick ratio (acid-test) for BMRN stock is 2.71.

What is the 5Y average quick ratio (acid-test) for BioMarin Pharmaceutical Inc. (BMRN)?

The 5Y average quick ratio (acid-test) for BMRN stock is 2.94.

What is the 10Y average quick ratio (acid-test) for BioMarin Pharmaceutical Inc. (BMRN)?

The 10Y average quick ratio (acid-test) for BMRN stock is 2.78.

What is the 15Y average quick ratio (acid-test) for BioMarin Pharmaceutical Inc. (BMRN)?

The 15Y average quick ratio (acid-test) for BMRN stock is 3.09.

What is the 20Y average quick ratio (acid-test) for BioMarin Pharmaceutical Inc. (BMRN)?

The 20Y average quick ratio (acid-test) for BMRN stock is 3.75.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	1.32
2026-03-31	4.20
2025-12-31	3.50
2025-09-30	3.10
2025-06-30	3.60
2025-03-31	3.49
2024-12-31	3.29
2024-09-30	2.62
2024-06-30	1.95
2024-03-31	1.70
2023-12-31	1.57
2023-09-30	1.65
2023-06-30	3.31
2023-03-31	3.21
2022-12-31	3.15
2022-09-30	3.54
2022-06-30	3.69
2022-03-31	3.28
2021-12-31	2.74
2021-09-30	3.03
2021-06-30	3.71
2021-03-31	3.66
2020-12-31	3.34
2020-09-30	2.38
2020-06-30	2.34
2020-03-31	1.72
2019-12-31	1.35
2019-09-30	2.53
2019-06-30	2.79
2019-03-31	2.76
2018-12-31	2.92
2018-09-30	2.26
2018-06-30	2.24
2018-03-31	2.29
2017-12-31	2.12
2017-09-30	3.81
2017-06-30	2.75
2017-03-31	2.85
2016-12-31	2.43
2016-09-30	3.50
2016-06-30	2.14
2016-03-31	1.79
2015-12-31	1.84
2015-09-30	2.34
2015-06-30	2.81
2015-03-31	4.25
2014-12-31	5.20
2014-09-30	4.23
2014-06-30	6.16
2014-03-31	6.85
2013-12-31	5.32
2013-09-30	3.37
2013-06-30	4.07
2013-03-31	4.08
2012-12-31	3.61
2012-09-30	4.44
2012-06-30	4.68
2012-03-31	3.25
2011-12-31	3.61
2011-09-30	4.46
2011-06-30	4.90
2011-03-31	5.18
2010-12-31	4.71
2010-09-30	5.02
2010-06-30	5.22
2010-03-31	5.35
2009-12-31	4.98
2009-09-30	6.94
2009-06-30	7.23
2009-03-31	5.04
2008-12-31	5.11
2008-09-30	5.21
2008-06-30	10.09
2008-03-31	11.80
2007-12-31	9.94
2007-09-30	12.43
2007-06-30	13.70
2007-03-31	7.55
2006-12-31	6.71
2006-09-30	7.25
2006-06-30	8.43
2006-03-31	6.34
2005-12-31	1.44
2005-09-30	1.68
2005-06-30	0.82
2005-03-31	1.01
2004-12-31	1.18
2004-09-30	1.82
2004-06-30	2.21
2004-03-31	13.77
2003-12-31	17.58
2003-09-30	15.65
2003-06-30	18.04
2003-03-31	12.17
2002-12-31	11.84
2002-09-30	10.95

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

1.32

2026-03-31

4.20

2025-12-31

3.50

2025-09-30

3.10

2025-06-30

3.60

2025-03-31

3.49

2024-12-31

3.29

2024-09-30

2.62

2024-06-30

1.95

2024-03-31

1.70

2023-12-31

1.57

2023-09-30

1.65

2023-06-30

3.31

2023-03-31

3.21

2022-12-31

3.15

2022-09-30

3.54

2022-06-30

3.69

2022-03-31

3.28

2021-12-31

2.74

2021-09-30

3.03

2021-06-30

3.71

2021-03-31

3.66

2020-12-31

3.34

2020-09-30

2.38

2020-06-30

2.34

2020-03-31

1.72

2019-12-31

1.35

2019-09-30

2.53

2019-06-30

2.79

2019-03-31

2.76

2018-12-31

2.92

2018-09-30

2.26

2018-06-30

2.24

2018-03-31

2.29

2017-12-31

2.12

2017-09-30

3.81

2017-06-30

2.75

2017-03-31

2.85

2016-12-31

2.43

2016-09-30

3.50

2016-06-30

2.14

2016-03-31

1.79

2015-12-31

1.84

2015-09-30

2.34

2015-06-30

2.81

2015-03-31

4.25

2014-12-31

5.20

2014-09-30

4.23

2014-06-30

6.16

2014-03-31

6.85

2013-12-31

5.32

2013-09-30

3.37

2013-06-30

4.07

2013-03-31

4.08

2012-12-31

3.61

2012-09-30

4.44

2012-06-30

4.68

2012-03-31

3.25

2011-12-31

3.61

2011-09-30

4.46

2011-06-30

4.90

2011-03-31

5.18

2010-12-31

4.71

2010-09-30

5.02

2010-06-30

5.22

2010-03-31

5.35

2009-12-31

4.98

2009-09-30

6.94

2009-06-30

7.23

2009-03-31

5.04

2008-12-31

5.11

2008-09-30

5.21

2008-06-30

10.09

2008-03-31

11.80

2007-12-31

9.94

2007-09-30

12.43

2007-06-30

13.70

2007-03-31

7.55

2006-12-31

6.71

2006-09-30

7.25

2006-06-30

8.43

2006-03-31

6.34

2005-12-31

1.44

2005-09-30

1.68

2005-06-30

0.82

2005-03-31

1.01

2004-12-31

1.18

2004-09-30

1.82

2004-06-30

2.21

2004-03-31

13.77

2003-12-31

17.58

2003-09-30

15.65

2003-06-30

18.04

2003-03-31

12.17

2002-12-31

11.84

2002-09-30

10.95

Quick Ratio (Acid-Test): 1.32

BMRN Quick Ratio

BMRN Average Quick Ratio (Acid-Test) Chart

BMRN Current vs Average Quick Ratio (Acid-Test) Chart

BMRN Quick Ratio (Acid-Test) Metrics

BMRN Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

BMRN Quick Ratio (Acid-Test) History

Related Metrics